Meridian Management »

Immunitybio shares owned by Meridian Management

Quarter-by-quarter ownership of Immunitybio (IBRX) shares owned by Meridian Management from 13F filings

Historical chart of Meridian Management investment in Immunitybio

Tip: Access up to 7 years of quarterly data

All positions including Immunitybio held by Meridian Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Immunitybio by Meridian Management

Quarter filed Position value Share count Share price at filing
2024-03-31 $54k 10k 5.37
2023-12-31 $46k 10k 4.58

More positions owned by Meridian Management

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Vanguard Intl Equity Index F Ftse Emr Mkt Etf (VWO)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Ishares Tr Intrm Gov Cr Etf (GVI)
Schwab Strategic Tr Us Sml Cap Etf (SCHA)
Vanguard Index Fds Mid Cap Etf (VO)
Ishares Tr Intl Eqty Factor (INTF)
Ishares Tr Core S&p Scp Etf (IJR)
Ishares Tr Tips Bd Etf (TIP)
Ishares Tr Core S&p Mcp Etf (IJH)
Wal-Mart Stores (WMT)
Corpay Com Shs
Alphabet Cap Stk Cl C (GOOG)
Meta Platforms Cl A (META)

View all positions for Meridian Management

Top funds holding Immunitybio

Vanguard Group
BlackRock
Geode Capital Management
Susquehanna International
Credit Suisse
Jpmorgan Chase & Co
Northern Trust
Rafferty Asset Management
Bank of America Corporation
Goldman Sachs Group
Charles Schwab Investment Management
Citigroup
Perceptive Advisors
Citadel Advisors
Sheets Smith Wealth Management

View all funds holding Immunitybio